Furthermore, because the risk of venom-induced anaphylaxis is increased in patients with ISM with coexisting HaT, it is recommended to test for KIT D816V if the baseline tryptase is >8 ng/ml and to perform BM biopsy if positive (45). This evidence concerns the gene KIT and anaphylaxis.